October 5, 2009 – TomTec launched the vascular analysis solution M’Ath1 (Measure of Atherosclerosis) as a further part of TomTec’s CardioArena multimodality imaging program during the European Society of Cardiology congress 2009 in Barcelona.
December 8, 2009 - At RSNA 2009 last week, Fujifilm introduced its Synapse cardiovascular version 4.0.4. This Web-based cardiovascular image and information management solution features additional third party integrations enabling clinicians to readily access relevant patient data stored in other locations.
AZE Ltd., a provider of advanced visualization solutions, provides 3D thin-client software Virtual Place distribution and technical support in North America.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine receptor agonist approved for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress, requires infrequent use of the drug aminophylline to reverse its effect in the case of adverse events.
October 5, 2009 - Philips Healthcare rolled out a new upgrade program for its Allura Xper family of cardiovascular X-ray devices, which includes remote technologies for remote proactive support, enabling Philips to automatically monitor each system and send alerts when issues arise.
October 2, 2009 – Cardiovascular magnetic resonance (CMR) in the evaluation of patients with heart failure (HF) “will expand substantially in the coming years,” according to the authors of a study published in October 2009 issue of the Journal of American College of Cardiology.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Philips Healthcare offers the 3D Heart Navigator interventional tool, which combines 3D CT images of a patients’ cardiac anatomy captured before a procedure into a single image with an overlay of the live X-ray fluoroscopy information.
October 2, 2009 – Verathon yesterday released the new AortaScan AMI 9700 aortic measurement instrument, which uses ultrasound to help physicians identify the presence of abdominal aortic aneurysms (AAA).
October 2, 2009 – Results from a multicenter study of Cheetah Medical's Exercise Cardiac Output (ECO) stress test protocol for chronic heart failure were published earlier this month in the Journal of Cardiac Failure, the official journal of the Heart Failure Society of America and the Japanese Heart Failure Society.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 2, 2009 – Resverlogix Corp. said this week results from the company's second clinical trial for the drug RVX-208 showed it increases the production of plasma ApoA-I, the key cardioprotective protein in high-density lipoprotein (HDL).
October 2, 2009 – CardioComm Solutions Inc. said yesterday it added the company’s wireless ECG management system to its suite of GEMS (Global ECG Management System) products. GEMS Air builds on the GEMS platform and incorporates software capable of continuously receiving and managing recordings of the heart’s activity over a wireless network instead of a land-line telephone network.
A broad array of contrast and injection management products for diagnostic imaging in radiology are provided with the EmpowerCTA Contrast Injector by ACIST Medical Systems Inc. The system is integrated with the IRiSCT Data Management System, provides a new level of integrative, informative and intuitive solutions to radiology suites around the world.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 1, 2009 - While we wait for the definition of "meaningful use," Dr. David Blumenthal, M.D., M.P.P., National Coordinator for Health Information Technology, recommends physicians become "as familiar as possible with the discussion of meaningful use criteria to date."
October 1, 2009 – Flexible Stenting Solutions Inc. (FSS) said this week it received conditional investigational device exemption (IDE) approval from the FDA for its FlexStent Femoropopliteal Self-Expanding Stent System so it can begin its U.S. clinical trial at up to 10 clinical sites and with 50 patients.
October 1, 2009 – Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for transcatheter mitral valve implantation (TMVI) system, announced successful results at TCT 2009 from its acute in vivo study.